Articles From: SunEdison Partners With AboitizPower To Develop Up To 300 Megawatts Of Utility-scale Solar Energy In The Philippines to CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Soft Tissue Sarcoma


3 Year Exclusive Partnership with a Leading Publicly Traded Independent Power Producer in the Philippines BELMONT, Calif.
Sign-up for SunEdison Partners With AboitizPower To Develop Up To 300 Megawatts Of Utility-scale Solar Energy In The Philippines investment picks
E*TRADE Financial Corporation (NASDAQ:ETFC) today announced plans to reduce its corporate debt outstanding by $400 million, while simultaneously effecting a refinance of existing notes to meaningfully extend its maturity profile.
Sign-up for E*TRADE Financial Corporation Announces Reduction of Corporate Debt and Public Offering of New Senior Notes investment picks
McDermott International, Inc. (NYSE:MDR) (“McDermott”) announced today that it has successfully delivered the riser support structure (“RSS”) for the INPEX-operated Ichthys LNG Project’s subsea umbilical, riser, flowline development.
Sign-up for McDermott Demonstrates Effective Project Execution with Milestone Delivery of Riser Support Structure for Ichthys Project investment picks
Company Confirms 2014 Guidance BRAINTREE, Mass., Nov.
Sign-up for Altra to Webcast 2014 Investor Day Today investment picks
Affymetrix, Inc. (NASDAQ: AFFX) today announced that the company will host a live webcast in conjunction with its Investor Day on Monday, November 17, 2014 at 11:30 a.m. ET.
Sign-up for Affymetrix Announces Webcast of Investor Day 2014 on Monday November 17, 2014 investment picks
Susquehanna Bancshares' stock (SUSQ) surged 34% in premarket trade Wednesday, after the Lititz, Penn.-based bank said it agreed to be acquired by BB&T Corp.
Sign-up for Susquehanna's stock soars on merger deal with BB&T investment picks
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share Canada NewsWire /NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES/ MISSISSAUGA, ON , Nov.
Sign-up for KP Tissue declares a Quarterly Dividend of $0.18 per Common Share investment picks
Don’t expect U.S. consumers to look to health insurers as their primary source of information when they have to make medical decisions, a new survey by Accenture (NYSE:ACN) indicates.
Sign-up for Most U.S. Consumers Believe Unbiased Information Trumps Accuracy When Making Medical Decisions, says Accenture Survey investment picks
NORWALK, Conn., Nov.
Sign-up for FactSet Research Systems Declares Dividend investment picks
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for Immune Design Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
Zep Inc. (NYSE: ZEP), a leading consumable chemical packaged goods company that manufactures a wide variety of high-performance maintenance and cleaning chemicals, today reported financial results for the three-month and twelve-month periods ended August 31, 2014.
Sign-up for Zep Inc. Reports Record Fiscal Fourth Quarter & Full Year 2014 Net Sales investment picks
LEXINGTON, Mass., Nov.
Sign-up for Curis to Present at the Stifel 2014 Healthcare Conference investment picks
Company to Host Conference Call Today, November 12, 2014, at 11:00 AM ET ST.
Sign-up for EnteroMedics Reports Third Quarter 2014 Financial Results investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference investment picks
Company demonstrates new 25G Ethernet MAC and PCS LogiCORE IP at Supercomputing 2014 SAN JOSE, Calif.
Sign-up for Xilinx Announces Industry's First Low Latency 25G Ethernet IP for FPGAs to Address Throughput Challenges in Data Center Applications investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) , a clinical-stage biopharmaceutical company whose lead product candidate, eravacycline, is being developed as a broad-spectrum intravenous and oral antibiotic designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) Gram-negative pathogens), today announced its participation in two upcoming investor conferences: A live audio webcast of the Stifel presentation will be available on the Company's website at http://ir.tphase.com/events.cfm .
Sign-up for Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences investment picks
bluebird bio, Inc. (Nasdaq:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today reported financial results and operational highlights for the quarter ended September 30, 2014.
Sign-up for bluebird bio Reports Fiscal Third Quarter 2014 Financial Results investment picks
The Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, a pilot initiative, will provide pro-bono oral care for 250-300 Holocaust survivors across nine North American cities MELVILLE, N.Y. , Nov.
Sign-up for Henry Schein and Alpha Omega International Dental Fraternity Answer the White House's Call to Action to Enhance the Quality of Life of Holocaust Survivors investment picks
Moody’s Corporation (NYSE:MCO) today announced that Raymond W.
Sign-up for Moody's Corporation Announces Change to Presentation Time at the Wells Fargo TMT Conference on November 13, 2014 in New York investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2014 and provided an update on its pipeline and CTP-354.
Sign-up for Concert Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Update on CTP-354 Program investment picks
Aradigm Corporation (Nasdaq:ARDM) (the “Company”) today announced that Igor Gonda, Aradigm’s President and Chief Executive Officer, will present an overview of the Company at the Stifel Healthcare Conference 2014 at the New York Palace Hotel in New York, New York on Tuesday, November 18, 2014 at 8:00 am Eastern time.
Sign-up for Aradigm to Present at the Stifel Healthcare Conference 2014 investment picks
Next-Generation MCUs for IoT, Sensor Fusion, Industrial Automation, Motor Control and Wireless Connectivity Applications Will Incorporate New Core SUNNYVALE, Calif.
Sign-up for Spansion Licenses ARM's High-Performance Cortex-M7 Processor investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: SunEdison Partners With AboitizPower To Develop Up To 300 Megawatts Of Utility-scale Solar Energy In The Philippines to CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Soft Tissue Sarcoma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent